| Article | Date | Source |
|---|
| Latisys Selects HP CloudSystem to Anchor Private Cloud Solution | -- | PRWeb - Biotechnology |
| Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i] | April 24, 2012 | Biotech News - PR Newswire |
| Index Ventures Launches New €150m Life Sciences Fund, with Investments from Two Leading Pharma Companies alongside Existing Anchor Limited Partners | March 21, 2012 | Pharma News - Business Wire |
| Groups try to anchor Obama in 'swamp' | February 02, 2012 | CNN Top Stories |
| Amarin Corporation PLC's Phase 3 ANCHOR Study Results Presented at American Heart Association's Scientific Sessions 2011 | November 16, 2011 | BioSpace - Breaking News |
| New Health Capital Partners annonce la clôture du fonds d'investissement avec Anchor Investment d'ORIX USA Asset Management | September 21, 2011 | Pharma News - Business Wire |
| New Health Capital Partners gibt Abschluss eines Investmentfonds mit Anchor Investment von ORIX USA Asset Management bekannt | September 21, 2011 | Pharma News - Business Wire |
| New Health Capital Partners Announces Closing of Investment Fund with Anchor Investment from ORIX USA Asset Management | September 20, 2011 | Pharma News - Business Wire |
| CNN sports anchor Nick Charles dies | June 26, 2011 | CNN Top Stories |
| Sand Hill Angels and Life Science Angels Anchor Oversubscribed $1.6 Million Investment in OncoHealth Corporation | May 03, 2011 | Biotech News - Business Wire |
| Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Significant Reductions in Triglycerides at Both 4 Gram and 2 Gram Doses and Statistically Significant Decrease in LDL-C | April 18, 2011 | Biotech News - PR Newswire |
| Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System | March 24, 2011 | Biotech News - PR Newswire |
| Anchor Therapeutics Achieves Milestone in GPCR Collaboration | January 07, 2011 | Pharma News - Business Wire |
| States set sights on 'anchor babies' | January 05, 2011 | CNN Top Stories |
| Amarin Corporation PLC Completes Patient Randomization in Phase 3 ANCHOR Trial | December 16, 2010 | BioSpace - Breaking News |
| Amarin Completes Patient Randomization in Phase 3 ANCHOR Trial | December 16, 2010 | Clinical Trials - PR Newswire |
| Anchor Therapeutics Publishes Discovery of Novel Pepducin as Potent Agonist of Stem Cell Receptor | December 08, 2010 | Pharma News - Business Wire |
| Veteran News Anchor Joins BASi | December 07, 2010 | Marketwire - Pharma and Biotech |
| CU's new biotech building will create anchor for sector | November 30, 2010 | Biotechnology - Moreover |
| Claris Lifesciences ropes in anchor investors | November 24, 2010 | Pharmaceutical - Moreover |
| Ariana and Bio-Rad Anchor HCV Diagnostic Collaborative | November 22, 2010 | Inside Industry - Gen |
| New York City Audience Applauds Speech By Cannabis Science CEO Dr. Robert Melamede at 'The Marijuana Conference;' CFO Richard Cowan on Panel Moderated by CNBC Anchor Trish Regan for New Program to Air In Early December Also Covered By Discovery Chan | October 27, 2010 | Medical Pharma - PR Newswire |
| Anchor Therapeutics, Inc.: Series B $10M | October 21, 2010 | OnBioVC |
| Anchor Therapeutics Named a “Fierce 15” Biotech Company for 2010 | September 15, 2010 | Pharma News - Business Wire |
| Seattle Doesn’t Need a Biotech Anchor Tenant. It Needs to Be a Place Where Startups Thrive | September 14, 2010 | Xconomy Life Sciences |
| Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News | September 10, 2010 | Xconomy Life Sciences |
| Anchor Therapeutics Announces Collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., Potential $480 Million in Milestones | September 09, 2010 | BioSpace |
| Anchor Therapeutics Announces Collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc.l, Potential $480M in Milestones | September 09, 2010 | BioSpace |
| Anchor lands $480M discovery pact with J&J unit | September 09, 2010 | FierceBiotech |
| Anchor Therapeutics Hooks Deal Worth Up to $480M with J&J | September 09, 2010 | Xconomy Life Sciences |
| Anchor Therapeutics Enters Into Collaborative Research, Option and License Agreement for its Pepducin Technology | September 09, 2010 | Pharma News - Business Wire |
| Anchor Sinks $10M Series B, Aileron Lands Deal with Roche, C Change Launches Fund With Vanterra, & More Boston-Area Deals News | August 25, 2010 | Xconomy Life Sciences |
| Anchor raises $10M, aims for more in Series B | August 20, 2010 | FierceBiotech |
| Anchor Therapeutics Secures $10 Million Series B Financing to Advance Pepducin Drug Candidates | August 20, 2010 | Pharma News - Business Wire |
| Anchor Therapeutics Nabs $10M for New Class of Peptide Drugs Against Hard Targets | August 20, 2010 | Xconomy Life Sciences |
| Anchor Therapeutics Adds Global Experts to Board of Directors and Scientific Advisory Board | July 21, 2010 | Biotech News - Business Wire |
| Bio-XCell to sign up three anchor tenants | May 05, 2010 | Biotechnology - Moreover |
| Dendreon CEO Mitch Gold: Seattle Biotech Has An Anchor Tenant Again | April 29, 2010 | Xconomy Life Sciences |
| Ascent Therapeutics opts for name change | March 30, 2010 | Health News - BizJournals.com |
| Renamed Anchor in talks for $30M round, new pact | March 30, 2010 | FierceBiotech |
| Ascent Changes to Anchor | March 30, 2010 | Xconomy Life Sciences |
| Ascent Therapeutics Changes Name to Anchor Therapeutics | March 30, 2010 | Biotech News - Business Wire |
| Strides Arcolab to hike stake in Ascent Pharmahealth | March 16, 2010 | Pharmaceutical - Moreover |
| Prominent Keynote Speakers, Rajiv Shah, M.D., Administrator, U.S. Agency for International Development and G. Steven Burrill, Founder and CEO, Burrill & Company, Anchor the Life Science Innovation Nor | February 25, 2010 | Biotechnology - Moreover |
| Prominent Keynote Speakers, Rajiv Shah, M.D., Administrator, U.S. Agency for International Development and G. Steven Burrill, Founder and CEO, Burrill & Company, Anchor the Life Science Innovation Northwest Conference 2010 | February 25, 2010 | Biotech News - Business Wire |
| Ascent Scientific Licenses Novel Columbia University Technology for High-Resolution Optical Imaging of Synaptic Activity in the Brain
| February 13, 2010 | PR Leap - Biotech |
| Real Intent Releases Ascent Lint Version 1.2 Offering New Rule Support With Low-Noise and High-Performance Linting | January 19, 2010 | Marketwire - Pharma and Biotech |
| Family ties anchor Boatwright | January 04, 2010 | Health News - BizJournals.com |
